HC Wainwright cuts Ionis Pharma price target to $100
HC Wainwright & Co. lowered its Ionis Pharmaceuticals price target to $100.00 a share from $115.00, while maintaining a Buy rating, according to TradingView News.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.